Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
EVGN

Evogene (EVGN) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $0.38 -5.0% on the day -71.6% over 12 months 52-week range $0.38 – $1.38

Share price and insider trades

EVGN closeInsider buyInsider sale
0.000.501.001.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $677 on 2026-06-04 · Gabi TarcicBought $294,400 on 2026-08-11 · Leon RecanatiBought $400,000 on 2026-08-04 · Leon Recanati
Bought, 12 months$694K
Sold, 12 months$0
Insiders buying1
Insiders selling0

Evogene insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $694K and 0 sold $0 of EVGN stock on the open market.

EVGN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $677 bought (1 trades)$677Q2 2026Q3 2026: $694K bought (2 trades)$694KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$694K2—0
Q2 2026$6771—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$6.0MBiotechnology
Profit margin0.0%Revenue growth -60.7%
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit−$216KOn all tracked purchases -31.1%

Summary

Over the past 12 months, 1 Evogene Ltd. insider reported open-market purchases totaling $694K, while 0 insiders reported sales totaling $0.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 26SEC Gabi TarcicChief Development Officer Buy 1,129new position $0.60 $677 -36.7% —
Aug 13SEC Leon RecanatiDirector Buy 460,0001,343,886 held (+52%) $0.64 $294K -40.6% —
Aug 5SEC Leon RecanatiDirector Buy 800,000883,886 held (+954%) $0.50 $400K -24.0% —

Insiders at Evogene Ltd.

InsiderBoughtSoldLast filingScore
Leon RecanatiDirector $694K — Aug 13, 2026 —
Gabi TarcicChief Development Officer $677 — Aug 26, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

EVGN stock: common questions

Are Evogene Ltd. insiders buying EVGN stock?

In the past 12 months, 1 insiders reported open-market purchases of EVGN worth $694K. The latest was Chief Development Officer Gabi Tarcic bought $677 of EVGN at $0.60 — first open-market purchase in our records; opens a new position.

Are Evogene Ltd. insiders selling EVGN stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is EVGN's 52-week range?

Over the past year EVGN has traded between $0.38 and $1.38. It last closed at $0.38 on Oct 9, 2026.